Clinical and Experimental Pediatrics

CrossRef Text and Data Mining

Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.

Treatment outcomes of high-dose chemotherapy plus stem cell rescue in high-risk neuroblastoma patients in Thailand

Kunanya Suwannaying, Piti Techavichit, Patcharee Komvilaisak, Napat Laoaroon, Nattee Narkbunnam, Kleebsabai Sanpakit, Kanhatai Chiengthong, Thirachit Chotsampancharoen, Lalita Sathitsamitphong, Chalongpon Santong, Panya Seksarn, Suradej Hongeng, Surapon Wiangnon

Clin Exp Pediatr. 2022;65(9):453-458. Published online May 24, 2022
DOI: https://doi.org/10.3345/cep.2022.00437

Treatment outcomes of high-dose chemotherapy plus stem cell rescue in high-risk neuroblastoma patients in Thailand

Clinical and Experimental Pediatrics. 2022;65(9):453-458

Link1

Link2 Link3

Treatment of poor-risk neuroblastoma patients with high-dose chemotherapy and autologous peripheral stem cell rescue

SL Cohn, TJ Moss, M Hoover, HM Katzenstein, PR Haut, ER Morgan, AA Green, M Kletzel

Bone Marrow Transplantation. 1997;20(7):543-551

Link1

Link2 Link3

Gonadal Failure Is Common in Long-Term Survivors of Childhood High-Risk Neuroblastoma Treated With High-Dose Chemotherapy and Autologous Stem Cell Rescue

Pauliina Utriainen, Anu Suominen, Outi Mäkitie, Kirsi Jahnukainen

Frontiers in Endocrinology. 2019;10:

Link1

Initial high dose chemotherapy plus autologous stem cell support improves survival outcomes compared with a standard CHOP regimen in people with higher intermediate risk aggressive lymphoma☆, ☆☆, ☆☆☆Abstracted from: Milpied N, Deconinck E, Gaillard F, et al. Initial treatment of aggressive lymphoma with high-dose chemotherapy and autologous stem-cell support. N Engl J Med 2004;350:1287–95.

A GLASMACHER

Cancer Treatment Reviews. 2004;30(6):577-582

Link1 Link2

High-Dose Chemotherapy with Busulfex and Melphalan As Conditioning Regimen Followed By Autologous STEM CELL Rescue for Pediatric Patients with High-Risk Neuroblastoma

Menachem Bitan, Maram Abu-yaman, Nitzan Cohen-Newman, Ronit Elhasid

Biology of Blood and Marrow Transplantation. 2014;20(2):S166

Link1 Link2

Initial high dose chemotherapy plus autologous stem cell support improves survival outcomes compared with a standard CHOP regimen in people with higher intermediate risk aggressive lymphoma

Axel Glasmacher

Cancer Treatment Reviews. 2004;30(6):577-582

Link1 Link2

Update on High-Dose Adjuvant Chemotherapy and Autologous Stem Cell Rescue in Patients with High-Risk Breast Cancer

Heather DeGrendele, Joyce A. O'Shaughnessy

Clinical Breast Cancer. 2003;4(3):173-175

Link1 Link2

High-Dose Chemotherapy and Autologous Hematopoietic Stem Cell Rescue for Children with High-Risk Neuroblastoma. Experience of a Single Pediatric Center in Bogotá, Colombia

M. Chaparro, M. Estupinan

Biology of Blood and Marrow Transplantation. 2012;18(2):S306

Link1 Link2

Secondary malignant neoplasms after high-dose chemotherapy and autologous stem cell rescue for high-risk neuroblastoma

Alissa Martin, Jennifer Schneiderman, Irene B. Helenowski, Elaine Morgan, Kimberley Dilley, Karina Danner-Koptik, Mohamad Hatahet, Hiroyuki Shimada, Susan L. Cohn, Morris Kletzel, Nobuko Hijiya

Pediatric Blood & Cancer. 2014;61(8):1350-1356

Link1 Link2 Link3

Late effects in high-risk neuroblastoma survivors treated with high-dose chemotherapy and stem cell rescue

Mahmoud M. Elzembely, Ann E. Dahlberg, Navin Pinto, Kasey J. Leger, Eric J. Chow, Julie R. Park, Paul A. Carpenter, K. Scott Baker

Pediatric Blood & Cancer. 2018;66(1):e27421

Link1 Link2